Product NDC: | 17478-010 |
Proprietary Name: | Inapsine |
Non Proprietary Name: | Droperidol |
Active Ingredient(s): | 2.5 mg/mL & nbsp; Droperidol |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-010 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA016796 |
Marketing Category: | NDA |
Start Marketing Date: | 19960701 |
Package NDC: | 17478-010-02 |
Package Description: | 10 AMPULE in 1 CARTON (17478-010-02) > 2 mL in 1 AMPULE |
NDC Code | 17478-010-02 |
Proprietary Name | Inapsine |
Package Description | 10 AMPULE in 1 CARTON (17478-010-02) > 2 mL in 1 AMPULE |
Product NDC | 17478-010 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Droperidol |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19960701 |
Marketing Category Name | NDA |
Labeler Name | Akorn, Inc. |
Substance Name | DROPERIDOL |
Strength Number | 2.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |